BR112013002145A2 - uso de hmgb1 como um marcador biológico das condições inflamatórias intestinais, método não-invasivo para detecção das mesmas em amostras fecais e respectivo kit - Google Patents

uso de hmgb1 como um marcador biológico das condições inflamatórias intestinais, método não-invasivo para detecção das mesmas em amostras fecais e respectivo kit

Info

Publication number
BR112013002145A2
BR112013002145A2 BR112013002145A BR112013002145A BR112013002145A2 BR 112013002145 A2 BR112013002145 A2 BR 112013002145A2 BR 112013002145 A BR112013002145 A BR 112013002145A BR 112013002145 A BR112013002145 A BR 112013002145A BR 112013002145 A2 BR112013002145 A2 BR 112013002145A2
Authority
BR
Brazil
Prior art keywords
hmgb1
kit
detecting
inflammatory bowel
biological marker
Prior art date
Application number
BR112013002145A
Other languages
English (en)
Portuguese (pt)
Inventor
Laura Stronati
Roberta Vitali
Salvatore Cucchiara
Original Assignee
Dmg Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dmg Italia Srl filed Critical Dmg Italia Srl
Publication of BR112013002145A2 publication Critical patent/BR112013002145A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR112013002145A 2010-08-05 2011-08-01 uso de hmgb1 como um marcador biológico das condições inflamatórias intestinais, método não-invasivo para detecção das mesmas em amostras fecais e respectivo kit BR112013002145A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM2010A000442A IT1406051B1 (it) 2010-08-05 2010-08-05 Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo.
PCT/IT2011/000276 WO2012017466A1 (en) 2010-08-05 2011-08-01 Use of hmgb1 as' a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof

Publications (1)

Publication Number Publication Date
BR112013002145A2 true BR112013002145A2 (pt) 2016-05-24

Family

ID=43739596

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013002145A BR112013002145A2 (pt) 2010-08-05 2011-08-01 uso de hmgb1 como um marcador biológico das condições inflamatórias intestinais, método não-invasivo para detecção das mesmas em amostras fecais e respectivo kit

Country Status (14)

Country Link
US (1) US20130137123A1 (enExample)
EP (1) EP2601525A1 (enExample)
JP (1) JP2013534313A (enExample)
CN (1) CN103069276A (enExample)
AU (1) AU2011287193B2 (enExample)
BR (1) BR112013002145A2 (enExample)
CA (1) CA2807107C (enExample)
CL (1) CL2013000223A1 (enExample)
EA (1) EA201390197A1 (enExample)
IL (1) IL223845A (enExample)
IT (1) IT1406051B1 (enExample)
MX (1) MX2013001327A (enExample)
PE (1) PE20131062A1 (enExample)
WO (1) WO2012017466A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
PT2968443T (pt) 2013-03-15 2021-12-28 Protagonist Therapeutics Inc Análogos de hepcidina e seus usos
SG10201810321PA (en) 2014-05-16 2018-12-28 Protagonist Therapeutics Inc α4β7 INTEGRIN THIOETHER PEPTIDE ANTAGONISTS
ES2977537T3 (es) 2014-07-17 2024-08-26 Protagonist Therapeutics Inc Inhibidores peptídicos orales del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias intestinales
WO2017117411A1 (en) 2015-12-30 2017-07-06 Protagonist Therapeutics, Inc. Analogues of hepcidin mimetics with improved in vivo half lives
WO2018089693A2 (en) * 2016-11-09 2018-05-17 Protagonist Therapeutics, Inc. Methods for determining and monitoring gastrointestinal inflammation
DK3622082T3 (da) 2017-05-12 2023-06-12 Evonik Operations Gmbh Fremgangsmåde til påvisning af c. perfringens-inducerede sygdomme i en fugleflok
IT201700083044A1 (it) 2017-07-20 2019-01-20 Laura Stronati “uso della gelsolina come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali”
IT201700083055A1 (it) 2017-07-20 2019-01-20 Laura Stronati “uso della proteina inibitore 2 della dissociazione di rho gdp come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali”
EP4501952A3 (en) 2018-02-08 2025-04-16 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
CA3092472A1 (en) * 2018-03-02 2019-09-06 Evonik Operations Gmbh In vitro method for detecting intestinal barrier failure in animals
CN109030817A (zh) * 2018-07-04 2018-12-18 长沙都正医学检验有限责任公司 Hmgb1检测试剂盒及其制备方法
ES2938227T3 (es) 2018-12-14 2023-04-05 Evonik Operations Gmbh Método in vitro de detección de disbiosis intestinal aviar
US11684653B2 (en) * 2019-03-06 2023-06-27 The Cleveland Clinic Foundation Compositions and method for reducing virulence of microorganisms
CN115279782A (zh) 2020-01-15 2022-11-01 詹森生物科技公司 白介素-23受体的肽抑制剂及其用于治疗炎性疾病的用途
IL294680A (en) 2020-01-15 2022-09-01 Janssen Biotech Inc Peptide inhibitors of the interleukin-23 receptor and their use for the treatment of inflammatory diseases
IL302996B2 (en) 2020-11-20 2025-04-01 Janssen Pharmaceutica Nv Compositions of interleukin-23 receptor peptide inhibitors
AU2022311814A1 (en) 2021-07-14 2024-02-29 Janssen Biotech, Inc. Lipidated peptide inhibitors of interleukin-23 receptor
CN116973572B (zh) * 2023-06-02 2025-03-07 东南大学附属中大医院 基于血、粪便铁蛋白检测评估肠屏障损伤严重程度的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1577671A1 (en) * 1996-07-17 2005-09-21 Kaneka Corporation Diagnostic drugs for autoimmune diseases
US6355623B2 (en) * 1998-09-24 2002-03-12 Hopital-Sainte-Justine Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
EP1601969A2 (en) * 2003-03-08 2005-12-07 Auvation Ltd Markers for colorectal cancer
WO2007001422A2 (en) * 2004-10-22 2007-01-04 Medimmune, Inc. High affinity antibodies against hmgb1 and methods of use thereof
WO2008075788A1 (ja) * 2006-12-20 2008-06-26 Shino-Test Corporation ヒトｈｍｇｂ１と特異的に結合する鳥類由来の抗体、ヒトｈｍｇｂ１の免疫学的測定方法及びヒトｈｍｇｂ１の免疫学的測定試薬
EP2185936A4 (en) * 2007-08-02 2010-08-04 Iss Immune System Stimulation DIAGNOSIS, STADIFICATION AND SURVEILLANCE OF INFLAMMATORY ABDOMINAL DISEASE
US7833721B2 (en) * 2008-03-14 2010-11-16 Exagen Diagnostics, Inc. Biomarkers for inflammatory bowel disease and irritable bowel syndrome

Also Published As

Publication number Publication date
PE20131062A1 (es) 2013-10-16
IT1406051B1 (it) 2014-02-06
IL223845A (en) 2016-06-30
US20130137123A1 (en) 2013-05-30
CA2807107A1 (en) 2012-02-09
WO2012017466A8 (en) 2013-07-11
CN103069276A (zh) 2013-04-24
AU2011287193B2 (en) 2015-08-13
MX2013001327A (es) 2013-03-08
EP2601525A1 (en) 2013-06-12
CA2807107C (en) 2017-01-03
JP2013534313A (ja) 2013-09-02
ITRM20100442A1 (it) 2012-02-06
EA201390197A1 (ru) 2013-06-28
AU2011287193A1 (en) 2013-06-13
CL2013000223A1 (es) 2014-03-28
WO2012017466A1 (en) 2012-02-09

Similar Documents

Publication Publication Date Title
BR112013002145A2 (pt) uso de hmgb1 como um marcador biológico das condições inflamatórias intestinais, método não-invasivo para detecção das mesmas em amostras fecais e respectivo kit
IL254144A0 (en) Methods for reprogramming cells and uses thereof
EP2554990A4 (en) METHOD OF MEASURING USING IMMUNOCHROMATOGRAPHY, TEST BAND FOR IMMUNOCHROMATOGRAPHY AND KIT OF MEASUREMENT REAGENTS FOR IMMUNOCHROMATOGRAPHY
DK2539465T3 (da) Analytsekventering med nanoporer
BR112013012460A2 (pt) "kit de diagnóstico para biomarcadores de benefício de saúde vaginal e método para a detecção de biomarcadoeres de benefício de saúde vaginal"
ES2644277T3 (es) Métodos de diagnóstico para determinar la prognosis del cáncer de pulmón de células no pequeñas
BRPI0820556A2 (pt) Bactéria e métodos para uso das mesmas
BR112013020454A2 (pt) método de diagnóstico de câncer e kit para diagnóstico usando medição de atividade de célula nk
BRPI1012340A8 (pt) proteínas de ligação específica e usos das mesmas
BRPI0919438A2 (pt) mistura de poliésteres, e, uso das misturas de poliésteres
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
FR2956486B1 (fr) Methode de diagnostic in situ de batteries par spectroscopie d'impedance electrochimique
BRPI1014708A2 (pt) dihidropirimidinonas para uso como inibidores de bace2
BRPI0908669A2 (pt) dispositivo para coletas de amostras e métodos de uso
BRPI1009420A2 (pt) axmi-001, axmi-002, axmi-030, e axmi-045; genes de toxina e métodos para seu uso
BRPI0920891A2 (pt) misturas de alfa-amilase e métodos para uso das referidas misturas
BR112013008410A2 (pt) sistema para uso em reparação tecidual
BRPI1007397A2 (pt) misturas de borrachas, método para a fabricação das misturas de borrachas e seu uso
BR112012005736A2 (pt) di-hidro benzocicloalquiloximetil oxazolapirimidinonas substituídas, preparação e uso das mesmas
BR112013010272A2 (pt) métodos analíticos e arranjos para uso nos mesmos
EP2404992A4 (en) SYSTEM FOR EVALUATING CELLS USING A CELLULAR SHEET AND METHOD OF USING THE SAME
SG11201500370SA (en) <i>IN VITRO</i> ASSAY FOR PREDICTING RENAL PROXIMAL TUBULAR CELL TOXICITY
EP2426495A4 (en) METHOD FOR DETECTING KIDNEY DISEASE BY MEASURING HUMAN MEGALIN IN THE HARN
BRPI0924180A2 (pt) lacases e métodos de uso das mesmas em baixa temperatura
BRPI1015445A2 (pt) método para detecção de uma substância em amostra biológica

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2525 DE 28-05-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.